Marcello Sanzi1,2, Alberto Aiolfi1, Jacopo Nicolò Marin1, Abd El Hakim Darawsh3, Davide Bona1. 1. Department of Biomedical Science for Health, Division of General Surgery, University of Milan, Istitituto Clinico Sant'Ambrogio, Milan, Italy. 2. Corresponding author: Dr Marcello Sanzi, Istituto Clinico Sant'Ambrogio, Via Luigi Giuseppe Faravelli, 16, 20149 Milan, Italy, marcello.sanzi@gmail.com. 3. Istituto Lombardo di Medicina Iperbarica, Milan, Italy.
Abstract
INTRODUCTION: This report describes the use of hyperbaric oxygen treatment (HBOT) to treat a case of colorectal anastomosis ischaemia following colorectal surgery. CASE REPORT: A 47-year-old man developed post-operative colorectal anastomosis ischaemia with leak after laparoscopic low anterior resection for T3N0 adenocarcinoma of the rectum. The leak with concomitant ischaemia presented 17 days after surgery. HBOT was administrated in 11 sessions over three weeks and the patient followed endoscopically and radiologically for two months. At two months the anastomosis showed both endoscopic and radiological healing; therefore the ileostomy was closed. Anal function was satisfactory with no incontinence or evidence of sepsis. CONCLUSIONS: Intra-operative or late leak with concomitant ischaemia of a colorectal anastomosis is a challenging event in colorectal surgery. HBOT may be beneficial in promoting healing in selected patients. Further studies are needed to evaluate conservative treatments and the role of HBOT. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.
INTRODUCTION: This report describes the use of hyperbaric oxygen treatment (HBOT) to treat a case of colorectal anastomosis ischaemia following colorectal surgery. CASE REPORT: A 47-year-old man developed post-operative colorectal anastomosis ischaemia with leak after laparoscopic low anterior resection for T3N0 adenocarcinoma of the rectum. The leak with concomitant ischaemia presented 17 days after surgery. HBOT was administrated in 11 sessions over three weeks and the patient followed endoscopically and radiologically for two months. At two months the anastomosis showed both endoscopic and radiological healing; therefore the ileostomy was closed. Anal function was satisfactory with no incontinence or evidence of sepsis. CONCLUSIONS: Intra-operative or late leak with concomitant ischaemia of a colorectal anastomosis is a challenging event in colorectal surgery. HBOT may be beneficial in promoting healing in selected patients. Further studies are needed to evaluate conservative treatments and the role of HBOT. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.
Authors: Robin J Brouwer; Alexander C Engberts; Boudewijn Ls Borger van der Burg; Thijs Tcf van Dongen; Rob A van Hulst; Rigo Hoencamp Journal: Diving Hyperb Med Date: 2018-09-30 Impact factor: 0.887
Authors: Cloë L Sparreboom; Julia T van Groningen; Hester F Lingsma; Michel W J M Wouters; Anand G Menon; Gert-Jan Kleinrensink; Johannes Jeekel; Johan F Lange Journal: Dis Colon Rectum Date: 2018-11 Impact factor: 4.585
Authors: Kenneth Loon; Simon Wilkins; Karen Oliva; Peter Carne; Andrew Fock; Geoff Frawley; Adrian Polglase; Paul McMurrick Journal: Int J Colorectal Dis Date: 2014-07-05 Impact factor: 2.571
Authors: Luis F Tapias; Cameron D Wright; Michael Lanuti; Ashok Muniappan; Daniel Deschler; Douglas J Mathisen Journal: Eur J Cardiothorac Surg Date: 2020-06-01 Impact factor: 4.191
Authors: Suna Guzel; Oguzhan Sunamak; Abdullah AS; Varol Celik; Mehmet Ferahman; Muhammed M K Nuri; Ertugrul Gazioglu; Pinar Atukeren; Ozgur Mutlu Journal: World J Gastroenterol Date: 2006-03-07 Impact factor: 5.742
Authors: Kurtuluş Açiksari; Seracettin Eğin; Gülçin Hepgül; Bengüsu Mirasoğlu; Gamze Tanriverdi; Devrim S Kanber; Sibel Demirci; Halil Doğan; Doğaç N Özüçelik; Akın S Toklu; İsmail Seçkin; Hakan T Yanar Journal: Diving Hyperb Med Date: 2019-12-20 Impact factor: 0.887